Gérard Amarenco
9
0
0
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 9 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
Fecal Incontinence Type Assessment Scale
Role: lead
Is the Severity of Urinary Disorders Related to Falls in People With Multiple Sclerosis
Role: lead
Determinants, Impact and Adherence Related to the Duration of Performing Self Catheterization on Patient Satisfaction and Quality of Life
Role: lead
Effect of Bladder Filling on Rectal Contractions During Cystometry
Role: lead
Time to be Ready to Void: a New Tool to Assess the Time Needed to Perform Micturition in Multiple Sclerosis
Role: lead
The Guarding Reflex Anal, Study of the Modulation Function of Rectal Distension
Role: lead
External Anal Sphincter Fatigability
Role: lead
What Are the Criteria for the Patient's Choice of Sel-catheterization Catheter
Role: lead
Effect of Need to Void on Rectal Sensory Function in Multiple Sclerosis
Role: lead
All 9 trials loaded